From: Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis
Variable | Point estimate | (Range) |
---|---|---|
Probabilities | ||
1.7% | (0.01-3.7%) | |
10% | (0-25%) | |
Costsa | ||
ED visit [39] | $553 | (442-664) |
Hospitalization [37] | ||
Infectious condition ruled out | $5550 | (4440-6660) |
Urinary tract infection | $5382 | (4305-6458) |
Bacteremia | $26,031 | (20,825-31,237) |
Meningitis | $29,464 | (23,571-35,357) |
Blood culture [27] | $12 | (10-14) |
CBC with differential [27] | $12 | (10-14) |
C-reactive protein [27] | $18 | (14-22) |
Procalcitonin [27] | $36 | (29-43) |
Urinalysis [27] | $4 | (3-5) |
Urine culture [27] | $11 | (9-13) |
Lumbar puncture [27] | $81 | (65-97) |
CSF culture [27] | $12 | (10-14) |
CSF gram stain [27] | $6 | (5-7) |
CSF testing, other [27] | $83 | (66-100) |
Utilities | ||
Well newborn [39] | 0.95 | |
Hospitalization [39] | 0.88 | (0.58-1.0) |
Bacteremia [24] | 0.71 | (0.4-1.0) |
Lumbar puncture [25] | − 0.1 | (0.0 - − 0.5) |
Disutility of death [38] | 30.98 |